<DOC>
	<DOC>NCT01118754</DOC>
	<brief_summary>The purpose of this study is to evaluate if DE-101 ophthalmic suspension will safely and effectively improve signs and or symptoms of dry eye disease.</brief_summary>
	<brief_title>Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<criteria>confirmed diagnosis of dry eye defined by protocol 18 years or older, and sign written informed consent negative pregnancy test and utilizing reliable contraceptive throughout study use of any topical ocular medications any ocular surgery within 90 days of study laser refractive surgery within one year of study ocular, lid disease/abnormalities that may interfere with the study corneal transplants uncontrolled systemic conditions females who are pregnant or nursing or planning a pregnancy, or females of childbearing potential who are not using a reliable method of contraception participated in another drug trial within 30 days prior to study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Santen</keyword>
	<keyword>Dry</keyword>
	<keyword>Eye</keyword>
</DOC>